Welcome to CKB CORE's new home! Please be sure to update any bookmarks you may have.
×

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03432897
Title BrUOG 337: Olaparib Prior to Radical Prostatectomy For Patients With Locally Advanced Prostate Cancer and Defects in DNA Repair Genes (337)
Acronym 337
Recruitment Terminated
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors Dr Anthony Mega
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST